Niqun Diping (尼群地平)尼群地平
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
批准文号:NMPA approval number: 国药准字H11021152
生产企业Manufacturer
- 北京太洋药业有限公司Chinese legal name: 北京太洋药业有限公司
主要成分Active Ingredients
- 二甲基--(-硝基苯基
- 二氢Er Qing
- 吡啶二甲酸甲乙酯Biding Erjia Suanjia Yizhi
药物知识说明
国药准字H11021152是一种在国家药监局注册认定的药品。该药品含有二氢、二甲基--(-硝基苯基、吡啶二甲酸甲乙酯-f1fb62eb等成分。
该药品关联的活性成分包括：二氢Er Qing、二甲基--(-硝基苯基Erjia Jixiao Jiben Ji、吡啶二甲酸甲乙酯Biding Erjia Suanjia Yizhi。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：北京太洋药业有限公司Chinese legal name: 北京太洋药业有限公司。
您可以探索含有相同成分的其他药品：二氢-fecab7ab成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 尼群地平) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 二氢Er Qing, 二甲基--(-硝基苯基Erjia Jixiao Jiben Ji, 吡啶二甲酸甲乙酯Biding Erjia Suanjia Yizhi.
Manufacturers recorded for this product: 北京太洋药业有限公司Chinese legal name: 北京太洋药业有限公司.
Explore other medicines containing the same ingredient: 二氢 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 尼群地平Recorded Chinese name: 尼群地平
- 规格Specification: ----
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 北京太洋药业有限公司Chinese legal name: 北京太洋药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H11021152
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H11021152
Manufacturer
Chinese legal name: 北京太洋药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H11021152
生产企业
北京太洋药业有限公司(国产)
适应症
适用于高血压、蛛网膜下腔出血。
用法用量
成人常用量：开始一次口服10mg（1片），每日1次，以后可根据情况调整为20mg（2片），每日2次。
不良反应
1.较少见的有头痛、面部潮红。|2.少见的有头晕、恶心、低血压、足踝部水肿、心绞痛发作，一过性低血压。|3.本品过敏者可出现过敏性肝炎、皮疹，甚至剥脱性皮炎等。
禁忌
对本品过敏及严重主动脉瓣狭窄的患者禁用。
注意事项
1.少数病例可能出现血碱性磷酸酶增高。|2.肝功能不全时血药浓度可增高，肾功能不全时对药代动力学影响小，以上情况慎用本品。|3.绝大多数患者服用此药后仅有可以耐受的轻度低血压反应，但个别患者可出现严重的体循环低血压症状。这种反应常发生在初期调整药量期间或者增加药物用量的时候，特别是合用β-受体阻滞剂时。故服用本品期间须定期测量血压。|4.已经证明极少数的患者，特别是那些有严重冠状动脉狭窄的患者，在服用此药或者增加剂量期间，心绞痛或心肌梗死的发生率增加。其机制尚不明了。故服用本品期间须定期作心电图。|5.少数接受β-受体阻滞剂的患者在开始服用此药后可发生心力衰竭，有主动脉狭窄的患者这种危险性更大。
贮藏
密封保存。
规格
----
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.